Norway's pivotal role in regulatory health economics and pharmaceutical cost containment - what can other countries learn?
- 31 May 1992
- journal article
- research article
- Published by Elsevier in Health Policy
- Vol. 21 (1) , 17-34
- https://doi.org/10.1016/0168-8510(92)90126-v
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- The Evaluation and Control of Drugs in NorwayInternational Journal of Technology Assessment in Health Care, 1986
- International Differences in Drug Regulation PhilosophyInternational Journal of Technology Assessment in Health Care, 1986